ea0063p421 | Adrenal and Neuroendocrine Tumours 2 | ECE2019
Hasse-Lazar Kornelia
, Kotecka-Blicharz Agnieszka
, Oczko-Wojciechowska Małgorzata
, Pawlaczek Agnieszka
, Michalik Barbara
, Gawlik Tomasz
, Jurecka-Lubieniecka Beata
, Krajewska Jolanta
, Krol Aleksandra
, Legutko Marta
, Czarniecka Agnieszka
, Zeman Marcin
, Jarzęb Barbara
Introduction: Germline mutations of RET oncogene result in development of multiple endocrine neoplasia type 2 (MEN 2). There is a strong correlation between type of the RET sequence changes and the aggressiveness of main syndrome feature, medullary thyroid carcinoma (MTC), and the incidence of remaining manifestations, mainly pheochromocytoma (PHEO). For many of the RET germline mutations, the clinical risk have been precisely defined, but there are ...